Plus Therapeutics Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 0/6

Plus Therapeutics has a total shareholder equity of $-7.6M and total debt of $3.3M, which brings its debt-to-equity ratio to -43.2%. Its total assets and total liabilities are $11.2M and $18.8M respectively.

Wichtige Informationen

-43.2%

Verhältnis von Schulden zu Eigenkapital

US$3.29m

Verschuldung

Zinsdeckungsgradn/a
BargeldUS$8.44m
Eigenkapital-US$7.62m
GesamtverbindlichkeitenUS$18.84m
GesamtvermögenUS$11.21m

Jüngste Berichte zur Finanzlage

Recent updates

Plus Therapeutics jumps 18% as JonesTrading adds another Buy rating

Oct 07

Plus Therapeutics finalizes $17.6M grant from Texas, to get initial funds by October end

Sep 22

Plus Therapeutics GAAP EPS of -$0.24 misses by $0.02

Jul 21

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: PSTV has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Langfristige Verbindlichkeiten: PSTV has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: PSTV has negative shareholder equity, which is a more serious situation than a high debt level.

Schulden abbauen: PSTV's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanz


Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: PSTV has less than a year of cash runway based on its current free cash flow.

Vorhersage Cash Runway: PSTV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.1% each year


Entdecken Sie finanziell stabile Unternehmen